What medical and pharmaceutical/bioscience/medical device meeting planners and continuing medical education professionals need to know to plan meetings and CME activities for healthcare professionals.
First there was the whole Vioxx and Celebrex thing. And now there's a new twist on an old drug: The FDA is doing a pilot study on the use of Ecstasy (methylenedioxymethamphetamine), better known for showing up in dance clubs than hospices, to help...
According to this editorial in the Calcutta's The Telegraph, physicians in India join the general public in not knowing much about AIDS, despite it being a huge problem in that country. ...
I should just unsubscribe from the pharma marketing listserv--it makes me crazy to see some of the stuff they write. The thread going around now is about how to use key opinion leaders for a more effective product launch. ...
Looks like blogger Benjamin Rosenbaum has pulled together ratings for tsunami relief organizations. So if you want to make sure your donations will be put to good use, this should prove to be a good resource. As he says, give wisely, generously...
While reports like this one recently have said that U.S. states wouldn't have the infrastructure in place to deal with a bioterrorism attack, CME providers have been doing a much better job in arming docs to fight an attack. According to this...
I haven't been writing about the tsunamis' horrifying impact on many countries in Asia because, well, it hurts my heart too much and makes me realize again how helpless we are in the face of a natural disaster of such proportions. (For links to...
Lots of interesting stuff in this article from the New York Times, "Program Coaxes Hospitals to See Treatments Under Their Noses." The point is to get docs in hospitals to remember to give standard-of-care treatments in three non-controversial...
